S-citalopram imprinted monolithic columns for capillary electrochromatography enantioseparations.
Derazshamshir A, Göktürk I, Yılmaz F, Denizli A.
Electrophoresis · research support, non-u.s. gov't; journal article · DOI 10.1002/elps.202100222 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för escitalopram. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
19 hitsCitalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.
Ji Y, Schaid DJ, Desta Z, Kubo M, Batzler AJ, Snyder K, Mushiroda T, Kamatani N, Ogburn E, Hall-Flavin D, Flockhart D, Nakamura Y, Mrazek DA, Weinshilboum RM.
Br J Clin Pharmacol · clinical trial; research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/bcp.12348A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Sanchez C, Reines EH, Montgomery SA.
Int Clin Psychopharmacol · comparative study; review-article; review; journal article · DOI 10.1097/yic.0000000000000023Debunking the placebo effect in depression: the effect of patient and investigator expectation on escitalopram efficacy.
Nehama Y, Rabinowitz I, Baruch Y, Mandel A, Lurie I, Barak Y.
Int Clin Psychopharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1097/yic.0000000000000013Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.
Hoare J, Carey P, Joska JA, Carrara H, Sorsdahl K, Stein DJ.
J Nerv Ment Dis · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/nmd.0000000000000082Clinical pharmacology review of escitalopram for the treatment of depression.
Pastoor D, Gobburu J.
Expert Opin Drug Metab Toxicol · review; journal article · DOI 10.1517/17425255.2014.863873Escitalopram-induced Parkinsonism.
Ak S, Anıl Yağcıoğlu AE.
Gen Hosp Psychiatry · journal article; case reports · DOI 10.1016/j.genhosppsych.2013.09.010Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.
Peltonen I, Männistö PT.
Basic Clin Pharmacol Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1742-7843.2010.00626.xEscitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.
Noehr-Jensen L, Zwisler ST, Larsen F, Sindrup SH, Damkier P, Brosen K.
Clin Pharmacol Ther · clinical trial, phase iii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1038/clpt.2009.154[Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
Encephale · review; journal article; english abstract · DOI 10.1016/j.encep.2007.11.001Escitalopram in the treatment of anxiety symptoms associated with depression.
Bandelow B, Andersen HF, Dolberg OT.
Depress Anxiety · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1002/da.20141Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
Kasper S, Spadone C, Verpillat P, Angst J.
Int Clin Psychopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1097/01.yic.0000194375.42589.c3Escitalopram: a review of its use in the management of anxiety disorders.
Dhillon S, Scott LJ, Plosker GL.
CNS Drugs · review; evaluation study; journal article · DOI 10.2165/00023210-200620090-00010Escitalopram: a review of its use in the management of major depressive disorder.
Murdoch D, Keam SJ.
Drugs · review; journal article · DOI 10.2165/00003495-200565160-00013Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria.
Hemels ME, Kasper S, Walter E, Einarson TR.
Curr Med Res Opin · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1185/030079904125003737Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry.
Gutteck U, Rentsch KM.
Clin Chem Lab Med · journal article · DOI 10.1515/cclm.2003.240R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
Sánchez C, Gruca P, Papp M.
Behav Pharmacol · journal article · DOI 10.1097/01.fbp.0000087733.21047.60Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF, Plosker GL.
Pharmacoeconomics · comparative study; review; journal article · DOI 10.2165/00019053-200321160-00004A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway.
François C, Toumi M, Aakhus AM, Hansen K.
Eur J Health Econ · journal article · DOI 10.1007/s10198-002-0139-0